Jose L. Relova
Santiago De Compostela, GA, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Dyskinesia-Hyperpyrexia Syndrome Following Subthalamic Deep Brain Stimulation, a Case Report.
Journal: Movement disorders clinical practice
Published: November 19, 2025
Obestatin treatment links mitochondrial homeostasis and skeletal muscle repair in Duchenne muscle dystrophy.
Journal: Molecular biomedicine
Published: June 27, 2025
Parkinson's Disease Symptoms Associated with Developing On-State Axial Symptoms Early after Subthalamic Deep Brain Stimulation.
Journal: Diagnostics (Basel, Switzerland)
Published: March 12, 2022
Continuous Subcutaneous Apomorphine Infusion before Subthalamic Deep Brain Stimulation: A Prospective, Comparative Study in 20 Patients.
Journal: Movement disorders clinical practice
Published: March 30, 2021
Concurrent Akt, ERK1/2 and AMPK Activation by Obestatin Inhibits Apoptotic Signaling Cascades on Nutrient-Deprived PC12 Cells.
Journal: Cellular and molecular neurobiology
Published: September 28, 2020
Obestatin signalling counteracts glucocorticoid-induced skeletal muscle atrophy via NEDD4/KLF15 axis.
Journal: Journal of cachexia, sarcopenia and muscle
Published: July 21, 2020
Publisher Correction: Obestatin controls skeletal muscle fiber-type determination.
Journal: Scientific reports
Published: December 16, 2018
Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment.
Journal: Journal of cachexia, sarcopenia and muscle
Published: December 19, 2017
Delayed complications of deep brain stimulation: 16-year experience in 249 patients.
Journal: Acta neurochirurgica
Published: May 04, 2017
Obestatin controls skeletal muscle fiber-type determination.
Journal: Scientific reports
Published: October 07, 2016
Last Updated: 09/26/2026